Evidence Review
World J Diabetes
13(6):422-433.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.422
Abstract (1094)
|
Core Tip (1099)
|
Full Article (HTML) (5399)
|
Tables (1-4) (1267)
|
Full Article (PDF)-727K (528)
|
Audio-1990K (21)
|
Peer-Review Report-250K (223)
|
Answering Reviewers-101K (212)
|
Received: 12/20/2021
|
Revised: 05/01/2022
|
Accepted: 05/23/2022
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (23)
|
Total Visits (14806)
|
Similar Articles (283)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
Cite
|
(0)
|
(0)
|
Open
Basic Study
Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
World J Diabetes
13(6):434-441.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.434
Abstract (975)
|
Core Tip (1026)
|
Article Highlights (1093)
|
Full Article (HTML) (3002)
|
Figures (1-3) (697)
|
Full Article (PDF)-850K (377)
|
Audio-285K (13)
|
Peer-Review Report-401K (217)
|
Answering Reviewers-153K (247)
|
Received: 01/27/2022
|
Revised: 04/24/2022
|
Accepted: 05/28/2022
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (12861)
|
Similar Articles (5)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (3)
|
Cite
|
(0)
|
(0)
|
Open
World J Diabetes
13(6):442-453.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.442
Abstract (1023)
|
Core Tip (1088)
|
Article Highlights (1118)
|
Full Article (HTML) (4106)
|
Figures (1-8) (726)
|
Full Article (PDF)-5732K (415)
|
Audio-276K (30)
|
Peer-Review Report-533K (211)
|
Answering Reviewers-58K (210)
|
Received: 03/01/2022
|
Revised: 04/25/2022
|
Accepted: 05/23/2022
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (14625)
|
Similar Articles (21)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (3)
|
Cite
|
(0)
|
(0)
|
Open
Retrospective Study
Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study
World J Diabetes
13(6):454-465.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.454
Abstract (918)
|
Core Tip (1111)
|
Article Highlights (1105)
|
Full Article (HTML) (2839)
|
Figures (1-3) (696)
|
Tables (1-3) (758)
|
Full Article (PDF)-1761K (388)
|
Audio-343K (20)
|
Peer-Review Report-225K (226)
|
Answering Reviewers-124K (187)
|
Received: 01/14/2022
|
Revised: 04/18/2022
|
Accepted: 05/28/2022
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (14399)
|
Similar Articles (159)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (3)
|
Cite
|
(0)
|
(0)
|
Open
Letter to the Editor
World J Diabetes
13(6):466-470.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.466
Abstract (987)
|
Core Tip (1066)
|
Full Article (HTML) (3425)
|
Tables (1-1) (704)
|
Full Article (PDF)-641K (471)
|
Audio-743K (14)
|
Peer-Review Report-179K (222)
|
Answering Reviewers-121K (183)
|
Received: 03/07/2022
|
Revised: 04/19/2022
|
Accepted: 05/23/2022
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11505)
|
Similar Articles (1)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
Cite
|
(0)
|
(0)
|
Open